PPBT241220C25000
- 0.05
- 0.000.00%
Purple Biotech Newsroom
Express News | Purple Biotech Shares Resume Trade
Express News | Purple Biotech Shares Halted On Circuit Breaker To The Downside, Stock Now Down -29.2%
Purple Biotech Secures $2.8 Million for Oncology Advancements
Purple Biotech Signs Securities Purchase Agreement
Purple Biotech | 6-K: Report of foreign private issuer (related to financial reporting)
PPBT Stock Surges 150% on Superior Efficacy of PDAC Combo Therapy
Express News | Purple Biotech Announces $2.8M Offering Of 472,668 ADS
Purple Biotech to Sell 472,668 ADSs at $6.00 in Registered Direct Offering
ADRs Advance; Purple Biotech Ltd. Climbs 150%
12 Health Care Stocks Moving In Monday's Pre-Market Session
Trending Stocks Today | Senti Biosciences Shoots up 445.37%
Express News | Purple Biotech Ltd. Shares Resume Trading
Express News | Purple Biotech Shares Halted On Circuit Breaker To The Upside, Stock Now Up 86.9%
Why Is Purple Biotech Stock Trading Higher On Monday?
Economic Data in Focus as US Equity Futures Waver Pre-Bell
Purple Biotech Shares Jump on Positive Phase 2 Cancer Drug Study Results
Top Premarket Gainers
Purple Biotech Reported Final Results From Phase 2 Study Of Its Lead Oncology Drug, CM24, In Patients With Pancreatic Ductal Adenocarcinoma
Express News | Purple Biotech Ltd - Biomarker Analysis Shows 79% Reduction in Risk of Death
Express News | Purple Biotech Reports Positive Final Results From Randomized Phase 2 Study of Cm24 in Second Line Pancreatic Cancer